Send to

Choose Destination

See 1 citation found by title matching your search:

Med Clin (Barc). 2014 Jan 21;142(2):85.e1-10. doi: 10.1016/j.medcli.2013.10.011. Epub 2013 Nov 21.

[Treatment of type 2 diabetes mellitus in patients with chronic kidney disease. Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica].

[Article in Spanish]

Author information

Sociedad Española de Medicina Interna (SEMI), España. Electronic address:
Sociedad Española de Nefrología (SEN), Grupo Español de Estudio de la Nefropatía Diabética (GEENDIAB), España.
Red de Grupos de Estudio de la Diabetes en Atención Primaria (redGDPS), España.
Sociedad Española de Diabetes (SED), España.


Chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) are highly prevalent chronic diseases, which represent an important public health problem and require a multidisciplinary management. T2DM is the main cause of CKD and it also causes a significant comorbidity with regard to non-diabetic nephropathy. Patients with diabetes and kidney disease represent a special risk group as they have higher morbi-mortality as well as higher risk of hypoglycemia than diabetic individuals with a normal kidney function. Treatment of T2DM in patients with CKD is controversial because of the scarcity of available evidence. The current consensus report aims to ease the appropriate selection and dosage of antidiabetic treatments as well as the establishment of safety objectives of glycemic control in patients with CKD.


Ancianos; Cardiovascular risk factors; Chronic kidney disease; Diabetes mellitus tipo 2; Elderly; Enfermedad renal crónica; Factores de riesgo cardiovascular; Type 2 diabetes mellitus

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center